Cocrystal Pharma Inc (COCP) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Cocrystal Pharma Inc

NASDAQ | COCP

1.43

USD

+0.01 (+0.70%)

AT CLOSE (AS OF Apr 2, 2025)

$15M

MARKET CAP

P/E Ratio

-1.84

EPS

$3.3

52 Week High

$1.4

52 Week Low

LIFE SCIENCES

Sector

COCP Chart

Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

COCP Technicals

Tags:

COCP Earnings

Yearly Income Statement (As of Dec 31, 2023)

Field	Value (USD)
Gross Profit	-$5.6M
Total Revenue	$575K
Cost Of Revenue	$6.2M
Costof Goods And Services Sold	-
Operating Income	-$19M
Selling General And Administrative	$6M
Research And Development	$15M
Operating Expenses	$19M
Investment Income Net	-
Net Interest Income	$640K
Interest Income	-
Interest Expense	-$640K
Non Interest Income	-$65K
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$189K
Income Before Tax	-
Income Tax Expense	-
Interest And Debt Expense	-$640K
Net Income From Continuing Operations	-$18M
Comprehensive Income Net Of Tax	-$18M
Ebit	-$19M
Ebitda	-$18M
Net Income	-$18M

Revenue & Profitability

Earnings Performance

COCP Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2023)

Field	Value (USD)
Total Assets	$31M
Total Current Assets	$29M
Cash And Cash Equivalents At Carrying Value	$26M
Cash And Short Term Investments	$26M
Inventory	-
Current Net Receivables	$890K
Total Non Current Assets	$2.2M
Property Plant Equipment	$271K
Accumulated Depreciation Amortization Ppe	$1.8M
Intangible Assets	-
Intangible Assets Excluding Goodwill	-
Goodwill	-
Investments	-
Long Term Investments	-
Short Term Investments	-
Other Current Assets	-
Other Non Current Assets	-
Total Liabilities	$4.9M
Total Current Liabilities	$3.3M
Current Accounts Payable	$1.2M
Deferred Revenue	-
Current Debt	-
Short Term Debt	-
Total Non Current Liabilities	$1.6M
Capital Lease Obligations	-
Long Term Debt	-
Current Long Term Debt	-
Long Term Debt Noncurrent	-
Short Long Term Debt Total	-
Other Current Liabilities	-
Other Non Current Liabilities	-
Total Shareholder Equity	$26M
Treasury Stock	-
Retained Earnings	-
Common Stock	$10K
Common Stock Shares Outstanding	$10M

yearly Cash Flow (As of Dec 31, 2023)

Field	Value (USD)
Operating Cashflow	-$15M
Payments For Operating Activities	-
Proceeds From Operating Activities	-
Change In Operating Liabilities	$2M
Change In Operating Assets	-$470K
Depreciation Depletion And Amortization	-
Capital Expenditures	$118K
Change In Receivables	-
Change In Inventory	-
Profit Loss	-$18M
Cashflow From Investment	-$118K
Cashflow From Financing	$4M
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	-
Dividend Payout Common Stock	-
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	$4M
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	$4M
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	-$18M

yearly Income Statement (As of Dec 31, 2023)

Field	Value (USD)
Gross Profit	-$5.6M
Total Revenue	$575K
Cost Of Revenue	$6.2M
Costof Goods And Services Sold	-
Operating Income	-$19M
Selling General And Administrative	$6M
Research And Development	$15M
Operating Expenses	$19M
Investment Income Net	-
Net Interest Income	$640K
Interest Income	-
Interest Expense	-$640K
Non Interest Income	-$65K
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$189K
Income Before Tax	-
Income Tax Expense	-
Interest And Debt Expense	-$640K
Net Income From Continuing Operations	-$18M
Comprehensive Income Net Of Tax	-$18M
Ebit	-$19M
Ebitda	-$18M
Net Income	-$18M

COCP Profile

Cocrystal Pharma Inc Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Cocrystal Pharma, Inc., a biotechnology company, is focused on the discovery and development of antiviral therapeutic treatments for serious and / or chronic viral diseases. The company is headquartered in Bothell, Washington.

Symbol	Price	Change %	Market Cap	Volume
DMN	$0.02	9.42%	-	742,693,504
NVDA	$101.80	-7.81%	$2.68T	334,149,797
INTC	$22.43	2.05%	$95.85B	240,924,655
F	$9.55	-5.96%	$39.53B	213,326,329
LCID	$2.32	-3.33%	$7.67B	210,875,217

Symbol	Price	Change %	Market Cap	Volume
JNJ	$160.56	3.35%	$399.65B	9,908,361
PG	$172.57	1.81%	$399.61B	6,993,394
NVO	$67.12	-1.65%	$308.32B	8,797,694
AZN	$74.03	2.50%	$225.70B	6,150,517
MRK	$86.38	-0.25%	$220.07B	12,113,104

Symbol	Price	Change %	Market Cap	Volume
VCIG	$5.99	1,796.17%	$26.40M	310,904
MKTW	$9.19	1,684.81%	$19.91M	117,875
MRM	$0.69	87.76%	$2.91M	53,662,982
PTIX	$0.42	84.14%	$4.04M	177,332,811
OSRH	$2.47	68.03%	$40.06M	89,471,971

Symbol	Price	Change %	Market Cap	Volume
ALDX	$1.42	-73.33%	$326.91M	21,865,554
RFAC	$2.70	-68.60%	$8.44M	605,339
PKBO	$0.02	-67.86%	$531.87K	66,140
TCBP	$0.50	-67.53%	$360.37K	1,955,586
OMQS	$0.04	-66.36%	$1.50M	950,669

Quick Links

COCP $1.43 (+0.70%) Quote details